Skip to content

Mazdutide

Also called IBI362 / LY3305677

Dual GLP-1/glucagon receptor agonist.

  • TypePeptide
  • FormInjectable
  • Researched forMetabolic & Fat Loss

Where to get Mazdutide

Flawless Compounds
Injectable
Code CAMERON

21+ to enter. The only form sold. Research compound, not approved for human use.

Shop injectable at Flawless Compounds

The short version

  • Why people research itFat oxidation, appetite and energy regulation, insulin sensitivity and endurance capacity.
  • What the evidence isApproved in China in 2025 and in late-stage trials elsewhere.
  • What to watchSevere upper belly pain that bores through to the back.

How Mazdutide works

Dual GLP-1/glucagon receptor agonist — incretin appetite control plus glucagon-driven energy expenditure and hepatic fat reduction.

Mazdutide is a GLP-1 and glucagon receptor dual agonist built on an oxyntomodulin backbone, and the ratio between its two arms is not published anywhere. Five registered-trial publications — a phase 1b, two phase 2s and two phase 3s Ji 2022 Zhang 2023 Ji 2023 Ji 2025 Gao 2026 — and not one prints a receptor potency ratio.

So derive it from the clinical data instead, which nobody does. The phase 2 in type 2 diabetes ran mazdutide against open-label dulaglutide in the same trial, which makes it the cleanest natural experiment in this cohort Zhang 2023. Over 20 weeks: HbA1c fell 1.41% to 1.67% on mazdutide and 1.35% on dulaglutide — essentially the same.

  • Injectable

On the goal map: Appetite & satiety signaling (Lose fat)

Research on Mazdutide5 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: Phase 3 human (China).

Human clinical evidence

  • Approved in China in 2025 and in late-stage trials elsewhere. A GLP-1/glucagon dual agonist licensed from Eli Lilly by Innovent, with phase 3 data in Chinese populations showing substantial weight loss.

  • The population matters when reading the numbers: the pivotal trials were run largely in Chinese participants at lower baseline BMI than Western obesity trials, so percentage results are not directly comparable to tirzepatide's.

Correlative data

  • Real-world use is essentially confined to China and very recent. Trial reports note the class-typical GI profile plus increased heart rate, which is the glucagon arm showing up.

How the mechanism reads

  • Based on oxyntomodulin, a naturally occurring gut hormone that intrinsically hits both GLP-1 and glucagon receptors — so this is a biomimetic design rather than an engineered chimera.

    Mechanistic
  • Same dual logic as survodutide: GLP-1 suppresses intake, glucagon raises expenditure and mobilizes liver fat. Trials have also reported reductions in hepatic fat and uric acid consistent with the glucagon component.

    Mechanistic

Sources

  • Ji L, et al. EClinicalMedicine 2022 · PMID 36247927
  • Zhang B, et al. Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. Diabetes Care 2023 · PMID 37943529
  • Ji L, et al. A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity. Nature Communications 2023 · PMID 38092790
  • Ji L, et al. Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight. New England Journal of Medicine 2025 · PMID 40421736
  • Gao L, et al. JAMA 2026 · PMID 42251595
  • Harrison SA, et al. Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study. Journal of Hepatology 2024 · PMID 39002641
  • Guo W, et al. Discovery of ecnoglutide - a novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog. Molecular Metabolism 2023 · PMID 37364710
  • Yang Y, et al. Impact of a dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta-analysis. Diabetes, Obesity and Metabolism 2023 · PMID 37860884
  • He L, et al. Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Internal Medicine 2022 · PMID 35344001
  • Stefanakis K, et al. The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation. Metabolism 2024 · PMID 39481534
  • Muller TD, et al. Anti-obesity drug discovery: advances and challenges. Nature Reviews Drug Discovery 2022 · PMID 34815532

Mazdutide safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Personal or family history of medullary thyroid cancer or MEN2: GLP-1 receptor agonists carry that rodent C-cell signal.
  • History of pancreatitis or gallstone disease: slowed gallbladder emptying and pancreatic stimulation are class effects.
  • Type 1 diabetes or insulin or sulfonylurea use: lower appetite plus GLP-1 action raises hypoglycemia risk.
  • Pregnancy or trying to conceive, and under 18.
  • Resting heart rate already high or a rhythm disorder: the glucagon arm tends to lift heart rate.

What’s expected

  • Smaller appetite and earlier fullness from GLP-1 action on the brainstem and slowed gastric emptying.
  • Nausea and loose stools early, easing as the body adapts.
  • Faster resting pulse, a known trait of glucagon receptor activation.
  • Falling liver fat, because the glucagon arm drives hepatic fat burning.

Watch for

  • Severe upper belly pain that bores through to the back.
  • Right-sided pain with fever or yellow eyes.
  • Neck lump, hoarseness or trouble swallowing.
  • Vomiting that will not stop, with dizziness from dehydration.

Labs that tell you it’s working

  • HbA1c (Hemoglobin A1c)
  • Lipase
  • Comprehensive Metabolic Panel (CMP)
  • Lipid Panel

Dual GLP-1 and glucagon agonist: GLP-1 explains appetite, pancreas and gallbladder effects; glucagon explains pulse and liver fat. PMID 36247927 PMID 38092790

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

A panel picked from how it works and what it can move: the tests, and why each is on it.

9 tests in one order
Marek Diagnostics · no doctor’s visit
Code CAMERON
Order this panel

Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.

The “On a GLP-1 (Semaglutide / Tirzepatide)” panel, explained

Mazdutide FAQ4 common questions

Is Mazdutide approved for human use?
No. Mazdutide is a research compound.
What is Mazdutide researched for?
Fat oxidation, appetite and energy regulation, insulin sensitivity and endurance capacity.
Which labs show whether it's doing anything?
HbA1c; Lipase; Comprehensive Metabolic Panel; Lipid Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Mazdutide: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Mazdutide is. Skool covers how it is run.

Free on this page

What Mazdutide is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Mazdutide is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool